Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

This measure sets up debate in the House on a bill about changing how fentanyl-related substances are listed under federal drug law. It does not make the drug law changes itself; it clears the way for the House to take up that separate bill .